Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06605222
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-14
Brief Title:
A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase III Open Label Multicenter Clinical Study to Evaluate the Safety Tolerability Pharmacokinetics and Efficacy of SHR-7787 in Patients With Advanced Solid Tumors
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is being conducted to evaluate safety tolerability pharmacokinetics and preliminary efficacy of SHR-7787 injection monotherapy for patients with advanced solid tumors To explore the reasonable dosage of SHR-7787 injection monotherapy for patients with advanced solid tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None